A 2022 International Survey on the Status of Prostate Cancer Theranostics

Thomas Beyer; Johannes Czernin; Lutz Freudenberg; Frederik Giesel; Marcus Hacker; Rodney J. Hicks; Bernd J. Krause

doi:10.2967/jnumed.122.264298

Research ArticleClinical Investigation

A 2022 International Survey on the Status of Prostate Cancer Theranostics

Thomas Beyer, Johannes Czernin, Lutz Freudenberg, Frederik Giesel, Marcus Hacker, Rodney J. Hicks and Bernd J. Krause

Journal of Nuclear Medicine January 2023, 64 (1) 47-53; DOI: https://doi.org/10.2967/jnumed.122.264298

Thomas Beyer

1QIMP Team, Centre Medical Physics and Biomedical Engineering, Medical University Vienna, Vienna, Austria;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

2Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lutz Freudenberg

3ZRN Rheinland, Korschenbroich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frederik Giesel

4Department of Nuclear Medicine, Medical Faculty, Heinrich-Heine-University and University Hospital Duesseldorf, Duesseldorf, Germany; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcus Hacker

5Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, Austria;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rodney J. Hicks

6The Department of Medicine, St Vincent’s Hospital, the University of Melbourne, Melbourne, Australia; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernd J. Krause

7Rostock University Medical Centre, Department of Nuclear Medicine, Rostock, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 1

January 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A 2022 International Survey on the Status of Prostate Cancer Theranostics

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

A 2022 International Survey on the Status of Prostate Cancer Theranostics

Thomas Beyer, Johannes Czernin, Lutz Freudenberg, Frederik Giesel, Marcus Hacker, Rodney J. Hicks, Bernd J. Krause

Journal of Nuclear Medicine Jan 2023, 64 (1) 47-53; DOI: 10.2967/jnumed.122.264298

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

A 2022 International Survey on the Status of Prostate Cancer Theranostics

Thomas Beyer, Johannes Czernin, Lutz Freudenberg, Frederik Giesel, Marcus Hacker, Rodney J. Hicks, Bernd J. Krause

Journal of Nuclear Medicine Jan 2023, 64 (1) 47-53; DOI: 10.2967/jnumed.122.264298

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers

Google Scholar

Keywords

prostate cancer
PSMA
theranostics
PET
survey

Main menu

User menu

Search

A 2022 International Survey on the Status of Prostate Cancer Theranostics

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords